Karyopharm Therapeutics Secures $20,500,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69fcbbd5-bf9b-41da-bfea-67467530b0e3&Preview=1
Date
5/2/2013
Company Name
Karyopharm Therapeutics
Mailing Address
2 Mercer Road Natick, MA 01760
Company Description
Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.
Website
http://www.karyopharm.com
Transaction Type
Venture Equity
Transaction Amount
$20,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed